We are investigating a new treatment for systemic lupus erythematosus in healthy individuals and those with the condition. The study includes participants from Chinese and Japanese backgrounds to see how the treatment works across different groups.
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the body's immune system mistakenly attacks healthy tissue, leading to inflammation and damage in various organs, including the skin, joints, and kidneys.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
